202 related articles for article (PubMed ID: 20854850)
1. EspA is a novel fusion partner for expression of foreign proteins in Escherichia coli.
Cheng Y; Gu J; Wang HG; Yu S; Liu YQ; Ning YL; Zou QM; Yu XJ; Mao XH
J Biotechnol; 2010 Nov; 150(3):380-8. PubMed ID: 20854850
[TBL] [Abstract][Full Text] [Related]
2. Preparation of bioactive soluble human leukemia inhibitory factor from recombinant Escherichia coli using thioredoxin as fusion partner.
Tomala M; Lavrentieva A; Moretti P; Rinas U; Kasper C; Stahl F; Schambach A; Warlich E; Martin U; Cantz T; Scheper T
Protein Expr Purif; 2010 Sep; 73(1):51-7. PubMed ID: 20381622
[TBL] [Abstract][Full Text] [Related]
3. New fusion protein systems designed to give soluble expression in Escherichia coli.
Davis GD; Elisee C; Newham DM; Harrison RG
Biotechnol Bioeng; 1999 Nov; 65(4):382-8. PubMed ID: 10506413
[TBL] [Abstract][Full Text] [Related]
4. An efficient strategy for high throughput screening of recombinant integral membrane protein expression and stability.
Fan J; Heng J; Dai S; Shaw N; Zhou B; Huang B; He Z; Wang Y; Jiang T; Li X; Liu Z; Wang X; Zhang XC
Protein Expr Purif; 2011 Jul; 78(1):6-13. PubMed ID: 21354311
[TBL] [Abstract][Full Text] [Related]
5. Rational recombinant XMRV antigen preparation and bead coupling for multiplex serology in a suspension array.
Sheikholvaezin A; Blomberg F; Ohrmalm C; Sjösten A; Blomberg J
Protein Expr Purif; 2011 Dec; 80(2):176-84. PubMed ID: 21871964
[TBL] [Abstract][Full Text] [Related]
6. Screening of genetic parameters for soluble protein expression in Escherichia coli.
Vernet E; Kotzsch A; Voldborg B; Sundström M
Protein Expr Purif; 2011 May; 77(1):104-11. PubMed ID: 21130169
[TBL] [Abstract][Full Text] [Related]
7. Expression and purification of functional Clostridium perfringens alpha and epsilon toxins in Escherichia coli.
Zhao Y; Kang L; Gao S; Zhou Y; Su L; Xin W; Su Y; Wang J
Protein Expr Purif; 2011 Jun; 77(2):207-13. PubMed ID: 21300155
[TBL] [Abstract][Full Text] [Related]
8. Dual expression system suitable for high-throughput fluorescence-based screening and production of soluble proteins.
Braud S; Moutiez M; Belin P; Abello N; Drevet P; Zinn-Justin S; Courçon M; Masson C; Dassa J; Charbonnier JB; Boulain JC; Ménez A; Genet R; Gondry M
J Proteome Res; 2005; 4(6):2137-47. PubMed ID: 16335960
[TBL] [Abstract][Full Text] [Related]
9. High level soluble production of functional ribonuclease inhibitor in Escherichia coli by fusing it to soluble partners.
Guo W; Cao L; Jia Z; Wu G; Li T; Lu F; Lu Z
Protein Expr Purif; 2011 Jun; 77(2):185-92. PubMed ID: 21292012
[TBL] [Abstract][Full Text] [Related]
10. The acidity of protein fusion partners predominantly determines the efficacy to improve the solubility of the target proteins expressed in Escherichia coli.
Su Y; Zou Z; Feng S; Zhou P; Cao L
J Biotechnol; 2007 May; 129(3):373-82. PubMed ID: 17374413
[TBL] [Abstract][Full Text] [Related]
11. An efficient method for expression in Escherichia coli and purification of the extracellular ligand binding domain of the human TGFbeta type II receptor.
Gasparian ME; Elistratov PA; Yakimov SA; Dolgikh DA; Kirpichnikov MP
J Biotechnol; 2010 Jul; 148(2-3):113-8. PubMed ID: 20451568
[TBL] [Abstract][Full Text] [Related]
12. Cloning, expression, and purification of the uropathogenic Escherichia coli invasin DraD.
Zalewska B; Piatek R; Cieślinski H; Nowicki B; Kur J
Protein Expr Purif; 2001 Dec; 23(3):476-82. PubMed ID: 11722186
[TBL] [Abstract][Full Text] [Related]
13. Escherichia coli malate dehydrogenase, a novel solubility enhancer for heterologous proteins synthesized in Escherichia coli.
Park JS; Han KY; Song JA; Ahn KY; Seo HS; Lee J
Biotechnol Lett; 2007 Oct; 29(10):1513-8. PubMed ID: 17549433
[TBL] [Abstract][Full Text] [Related]
14. Expression of foreign proteins in Escherichia coli by fusing with an archaeal FK506 binding protein.
Ideno A; Furutani M; Iwabuchi T; Iida T; Iba Y; Kurosawa Y; Sakuraba H; Ohshima T; Kawarabayashi Y; Maruyama T
Appl Microbiol Biotechnol; 2004 Mar; 64(1):99-105. PubMed ID: 14564491
[TBL] [Abstract][Full Text] [Related]
15. Soluble expression of archaeal proteins in Escherichia coli by using fusion-partners.
Kim S; Lee SB
Protein Expr Purif; 2008 Nov; 62(1):116-9. PubMed ID: 18657619
[TBL] [Abstract][Full Text] [Related]
16. Overexpression and refolding of thioredoxin/TRAIL fusion from inclusion bodies and further purification of TRAIL after cleavage by enteropeptidase.
Gasparian ME; Ostapchenko VG; Yagolovich AV; Tsygannik IN; Chernyak BV; Dolgikh DA; Kirpichnikov MP
Biotechnol Lett; 2007 Oct; 29(10):1567-73. PubMed ID: 17609857
[TBL] [Abstract][Full Text] [Related]
17. Proteome-based identification of fusion partner for high-level extracellular production of recombinant proteins in Escherichia coli.
Qian ZG; Xia XX; Choi JH; Lee SY
Biotechnol Bioeng; 2008 Oct; 101(3):587-601. PubMed ID: 18727129
[TBL] [Abstract][Full Text] [Related]
18. The N-domain of Escherichia coli phosphoglycerate kinase is a novel fusion partner to express aggregation-prone heterologous proteins.
Song JA; Lee DS; Park JS; Han KY; Lee J
Biotechnol Bioeng; 2012 Feb; 109(2):325-35. PubMed ID: 21882174
[TBL] [Abstract][Full Text] [Related]
19. Generation of monoclonal antibodies for the assessment of protein purification by recombinant ribosomal coupling.
Kristensen J; Sperling-Petersen HU; Mortensen KK; Sørensen HP
Int J Biol Macromol; 2005 Dec; 37(4):212-7. PubMed ID: 16330094
[TBL] [Abstract][Full Text] [Related]
20. Highly efficient protein expression and purification using bacterial hemoglobin fusion vector.
Kwon SY; Choi YJ; Kang TH; Lee KH; Cha SS; Kim GH; Lee HS; Kim KT; Kim KJ
Plasmid; 2005 May; 53(3):274-82. PubMed ID: 15848232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
